Corbus Pharmaceuticals Holdings, Inc.盘中异动临近午盘大幅拉升5.06%报17.02美元

市场透视10-30

北京时间2024年10月30日23时49分，Corbus Pharmaceuticals Holdings, Inc.（CRBP.us）股票出现波动，股价快速上涨5.06%。截至发稿，该股报17.02美元/股，成交量8.5111万股，换手率0.71%，振幅6.64%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-10.00百万美元，每股收益-0.90美元，毛利-200000.00美元，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2479773517?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-10-30 23:49","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2479773517","market":"us","top_or_hot":-1,"title":"Corbus Pharmaceuticals Holdings, Inc.盘中异动 临近午盘大幅拉升5.06%报17.02美元","media":"市场透视","content":"<div>\n<p>北京时间2024年10月30日23时49分，Corbus Pharmaceuticals Holdings, Inc.（CRBP.us）股票出现波动，股价快速上涨5.06%。截至发稿，该股报17.02美元/股，成交量8.5111万股，换手率0.71%，振幅6.64%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-10.00百万美元，每股收益-0.90美元，毛利-200000.00美元，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103023490998e3f768&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Corbus Pharmaceuticals Holdings, Inc.盘中异动 临近午盘大幅拉升5.06%报17.02美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCorbus Pharmaceuticals Holdings, Inc.盘中异动 临近午盘大幅拉升5.06%报17.02美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-30 23:49 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103023490998e3f768&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年10月30日23时49分，Corbus Pharmaceuticals Holdings, Inc.（CRBP.us）股票出现波动，股价快速上涨5.06%。截至发稿，该股报17.02美元/股，成交量8.5111万股，换手率0.71%，振幅6.64%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-10.00百万美元，每股收益-0.90美元，毛利-200000.00美元，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103023490998e3f768&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CRBP","symbol_name":"Corbus Pharmaceuticals Holdings, Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103023490998e3f768&s=b","article_id":"2479773517","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103023490998e3f768&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2479773517","pubTimestamp":1730303349,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年10月30日23时49分，Corbus Pharmaceuticals Holdings, Inc.股票出现波动，股价快速上涨5.06%。Corbus Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.43%。Corbus Pharmaceuticals Holdings, Inc.公司简介：Corbus Pharmaceuticals Holdings Inc 是一家拥有多元化产品组合的精准肿瘤学公司，致力于通过将科学方法引入人们熟知的生物途径来帮助人们战胜严重疾病。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"CRBP":"Corbus Pharmaceuticals Holdings, Inc.","BK4139":"生物科技"},"translate_title":"Corbus Pharmaceuticals Holdings, Inc. surged 5.06% to $17.02 near midday","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CRBP":1},"content_text":"北京时间2024年10月30日23时49分，Corbus Pharmaceuticals Holdings, Inc.（CRBP.us）股票出现波动，股价快速上涨5.06%。截至发稿，该股报17.02美元/股，成交量8.5111万股，换手率0.71%，振幅6.64%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-10.00百万美元，每股收益-0.90美元，毛利-200000.00美元，市盈率-2.94倍。机构评级方面，在所有8家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Corbus Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.43%。其相关个股中，Tharimmune, Inc.、Ensysce Biosciences, Inc.、Calcimedica, Inc.涨幅较大，Tharimmune, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm (Holdings) Plc较为活跃，换手率分别为4733.06%、2584.62%、127.15%，振幅较大的相关个股有Tharimmune, Inc.、Ensysce Biosciences, Inc.、Quince Therapeutics, Inc.，振幅分别为110.34%、77.90%、47.63%。Corbus Pharmaceuticals Holdings, Inc.公司简介：Corbus Pharmaceuticals Holdings Inc 是一家拥有多元化产品组合的精准肿瘤学公司，致力于通过将科学方法引入人们熟知的生物途径来帮助人们战胜严重疾病。 该公司的产品线包括： CRB-701 ，一种下一代抗体药物偶联物 (ADC)，会针对癌细胞上 Nectin-4 的表达，释放细胞毒性有效负载；CRB-601 ，一种抗整合素单克隆抗体，可阻断癌细胞上表达的 TGF 的激活。 CRB-913 ，一种第二代外周限制性 CB1 受体反向激动剂，旨在治疗肥胖症。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2479773517"}

Corbus Pharmaceuticals Holdings, Inc.盘中异动 临近午盘大幅拉升5.06%报17.02美元

精彩评论

Corbus Pharmaceuticals Holdings, Inc.盘中异动临近午盘大幅拉升5.06%报17.02美元